等待開盤 05-09 09:30:00 美东时间
+0.840
+6.58%
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
BTIG analyst David Larsen maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $15 to $17.
05-05 18:16
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
今日重点评级关注:Oppenheimer:维持Alumis"跑赢大市"评级,目标价从50美元升至55美元;美银证券:维持Rocket Pharmaceuticals"买入"评级,目标价从8美元升至9美元
03-31 16:30
Craig-Hallum analyst Matthew Hewitt initiates coverage on CryoPort (NASDAQ:CYRX) with a Buy rating and announces Price Target of $15.
03-30 23:24
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Wall Street analysts changed outlook on top names. For full view of changes, including upgrades/downgrades, see analyst ratings page.
03-04 20:35
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $12 to $13.
03-04 17:34
The earnings results for CryoPort (NASDAQ:CYRX) for Q4 were made public on Tues...
03-04 05:12
CryoPort (NASDAQ:CYRX) sees FY2026 sales of $190.000 million-$194.000 million vs $189.493 million analyst estimate.
03-04 05:11